You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Genos customers have until June 22 to dowload their exome and variant data from the Genos portal before it will no longer be accessible.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
Fulgent saw a 75 percent increase year over year in billable tests, leading to revenues of $7.8 million. It also withdrew its 2020 full-year revenue guidance.
Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.
Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.
The Wall Street Journal looks into why some people who learn family secrets through genetic testing share that information publicly.
Consumers have filed complaints about the San Diego-based firm's questionable business practices and lack of response in the last year.
TechCrunch reports that a California state senator is introducing a bill to increase the regulation of direct-to-consumer genetic testing companies.
CNBC discusses factors contributing to the state of direct-to-consumer genetic testing.
Italy's Dante Labs is building one of Europe's largest genomic labs and leading an effort to sequence 100,000 whole genomes around the Mediterranean.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.